THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™
The Savicell™ Well-Shield™ platform is a blood test inherently designed for the early detection of disease.
Cancer is our first focus.
Savicell™ has a first-in-class liquid ImmunoBiopsy™ platform designed for the early detection of disease. The platform identifies multiple diseases and may be used to track treatment effectiveness, including immunotherapy. The Company’s initial focus is on the multi-billion dollar, underserved cancer liquid biopsy market.
Metabolic changes in the immune system modulate cell fate and function, influencing immune response outcomes. These energy changes give the immune system the ability (effector function) to attack disease, including cancer. Diseases produce unique signatures in immune metabolic profiles that ImmunoBiopsy™ uses to distinguish between and within various ailments, such as cancers, autoimmune diseases, and infectious diseases. Savicell’s Liquid ImmunoBiopsy measures the energy changes of the immune system, which are disease-specific, and identifies the ailment.
Company Details
- Employees
- 9
- Address
- Matam Advanced Technology Park, Haifa,israel 3190501,israel
- in****@****ell.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- savicell.com
- Keywords
- IT Consulting.
- HQ
- Haifa, Israel
Savicell Questions
Savicell's website is savicell.com
Savicell's LinkedIn profile is https://il.linkedin.com/company/savicell
Savicell has
9 employees.
View email and phone details for 9
employees at Savicell.
Savicell's industry is
Biotechnology Research
Savicell's top competitors are
Cybonet Security,
Pluri,
Remedy Cell Ltd.,
Cyfox,
Intuitive,
Wideops Ltd,
Alma Technologies Ltd,
Memed,
Axilion Smart Mobility - Ai (Tlv:ailn),
Ever After Foods.
Savicell's support email address is info@savicell.com
Savicell's categories are Biotechnology Research
